Rintu Thomas

TitlePostdoc Fellows and Associates
InstitutionBaylor College of Medicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Thomas R, Jerome JM, Dang TD, Souto EP, Mallam JN, Rowley DR. Androgen receptor variant-7 regulation by tenascin-c induced src activation. Cell Commun Signal. 2022 08 10; 20(1):119. PMID: 35948987; PMCID: PMC9364530.
    2. Tran LL, Dang T, Thomas R, Rowley DR. ELF3 mediates IL-1a induced differentiation of mesenchymal stem cells to inflammatory iCAFs. Stem Cells. 2021 12; 39(12):1766-1777. PMID: 34520582; PMCID: PMC8963131.
      Citations: 1     Fields:    Translation:HumansCells
    3. Thomas R, Weihua Z. Rethink of EGFR in Cancer With Its Kinase Independent Function on Board. Front Oncol. 2019; 9:800. PMID: 31508364; PMCID: PMC6716122.
      Citations: 33     
    4. Thomas R, Srivastava S, Katreddy RR, Sobieski J, Weihua Z. Kinase-Inactivated EGFR Is Required for the Survival of Wild-Type EGFR-Expressing Cancer Cells Treated with Tyrosine Kinase Inhibitors. Int J Mol Sci. 2019 May 22; 20(10). PMID: 31121829; PMCID: PMC6566606.
      Citations: 10     Fields:    Translation:HumansCells
    5. Katreddy RR, Bollu LR, Su F, Xian N, Srivastava S, Thomas R, Dai Y, Wu B, Xu Y, Rea MA, Briggs JM, Zhang Q, Lu X, Huang G, Weihua Z. Targeted reduction of the EGFR protein, but not inhibition of its kinase activity, induces mitophagy and death of cancer cells through activation of mTORC2 and Akt. Oncogenesis. 2018 Jan 23; 7(1):5. PMID: 29358623; PMCID: PMC5833766.
      Citations: 12     
    Thomas's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (24)
    Co-Authors (4)
    Similar People (60)
    Same Department Expand Description